The compound MA-0204 has been shown to specifically increase PPARβ/δ target genes and improve the utilization of fatty acids in myoblasts isolated from a DMD patient (Lagu et al., 2018b). The gene discussed is PPARD; the disease is Duchenne muscular dystrophy.